Bayer Schering Pharma
Focus on therapeutic areas with a high medical need
Improving patients' quality of life with innovations
Bayer Schering Pharma invests large sums in research and development to improve patients' quality of life and prolong their lives. The focus is on therapeutic areas with a high medical need, where even more innovations are needed despite considerable progress. In this context, Bayer Schering Pharma focuses on its core competencies and its many years of experience. We thus hold a leading position in many therapeutic fields: for instance, in the treatment of hemophilia and multiple sclerosis, in contrast media and oral contraception. We are also striving for such a leading position in oncology.
top of pageInnovation – even on established products
In addition to engaging in research on new therapeutic approaches and the clinical development of new active substances, Bayer Schering Pharma also further develops products that have already been approved and are on the market. This product-accompanying development aims at identifying the additional potential of an active substance in other indication areas, thus extending its range of application. This includes improving existing formulations and administration forms.
- Link: More information on the Bayer Schering Pharma Division
- Link: Clinical trials registry and results